Skip to content

We are pleased to announce that the PolyPeptide Group received the certificate granted by the European Directorate for the Quality of Medicines for Generic Desmopressin on December 22, 2008. Certificate number: RO-CEP 2006-266-Rev 00.

View EU Specification

Desmopressin: US Specification

PDF Version [36 KB PDF]

Molecular weight: 1069
Desmopressin
Sequence:
  _________________________
  |                                                         |
SCH2CH2CO-Tyr-Phe-Gln-Asn-Cys-
Pro-D-Arg-Gly-NH2 Acetate salt
Last update: 12 SEP 2007
Available registration documents (CTD format): US DMF, CEP/COS certificate

Please note that regional minor differences in analytical procedures and acceptance criteria might occur.

 

TEST ACCEPTANCE CRITERIA ANALYTICAL PROCEDURE
CHARACTERS
Appearance
A white powder

 
Visual inspection
IDENTIFICATION
Identification, HPLC
Retention time of main peak corresponds to the retention time of reference sample

 
In-house
Amino acid analysis
Asp: 0.95 to 1.05
Glu: 0.95 to 1.05
Pro: 0.95 to 1.05
Gly: 0.95 to 1.05
Cys: 0.95 to 1.05
Tyr: 0.95 to 1.05
Phe: 0.95 to 1.05
Arg: 0.95 to 1.05
Not more than traces of other amino acids

 
Ph.Eur.

Other specifications of Desmopressin:


PURITY
Related substances, HPLC:     In-house
Any individual impurity ≤ 0.5%  
Total amount ≤ 1.5%  
ASSAY
Mass balance 95.0 to 105.0% Calculation
OTHER TESTS
Acetic acid 3.0 to 8.0% Ph.Eur.
Water ≤ 6.0% USP/Ph.Eur.
Specific optical rotation -82 to -72 USP/Ph.Eur.
RESIDUAL SOLVENTS
Ethanol ≤ 0.5% In-house
MICROBIOLOGICAL TESTS
Total viable aerobic count < 100 CFU/g USP/Ph.Eur.
Bacterial endotoxins < 500 IU/mg

 
USP/Ph.Eur.


 
 

Desmopressin: EU Specification

EU Specification PDF Version [40 KB PDF]

Molecular weight: 1069
Desmopressin
Sequence:
  _________________________
  |                                                         |
SCH2CH2CO-Tyr-Phe-Gln-Asn-Cys-
Pro-D-Arg-Gly-NH2 Acetate salt
Last update: 12 SEP 2007
Available registration documents (CTD format): CEP/COS certificate

Please note that regional minor differences in analytical procedures and acceptance criteria might occur.

 

TEST ACCEPTANCE CRITERIA ANALYTICAL PROCEDURE
CHARACTERS
Appearance
A white powder

 
Visual inspection
IDENTIFICATION
Identification, HPLC
Retention time and size of main peak correspond to that of reference

 
In-house
Amino acid analysis
Asp: 0.95 to 1.05
Glu: 0.95 to 1.05
Pro: 0.95 to 1.05
Gly: 0.95 to 1.05
Cys: 0.95 to 1.05
Tyr: 0.95 to 1.05
Phe: 0.95 to 1.05
Arg: 0.95 to 1.05
Not more than traces of other amino acids

 
Ph.Eur.

Other specifications of Desmopressin:


PURITY
Related substances, HPLC:     In-house
[Asp5]desmopressin ≤ 0.4%  
[Glu4]desmopressin ≤ 0.4%  
[Gly9OH]desmopressin ≤ 0.4%  
[L-Arg8]desmopressin ≤ 0.4%  
[Gln4(Acm)]desmopressin and    
[Asn5(Acm)]desmopressin ≤ 0.4%  
[Gly9N(CH3)2]desmopressin ≤ 0.4%  
Any other individual impurity ≤ 0.3%  
Total amount ≤ 1.5%  
ASSAY
Mass balance 95.0 to 105.0% Calculation
OTHER TESTS
Acetic acid 3.0 to 8.0% Ph.Eur.
Water ≤ 6.0% USP/Ph.Eur.
Specific optical rotation -82 to -72 USP/Ph.Eur.
RESIDUAL SOLVENTS
Ethanol ≤ 0.5% In-house
MICROBIOLOGICAL TESTS
Total viable aerobic count < 100 CFU/g USP/Ph.Eur.
Bacterial endotoxins < 500 IU/mg

 
USP/Ph.Eur.
For more information on Desmopressin, samples or orders contact us.